Valuation: AbbVie Inc.

Market Cap 463B 401B 378B 343B 644B 44,336B 648B 4,518B 1,741B 22,492B 1,737B 1,699B 71,505B P/E 2026 *
33.5x
P/E 2027 * 24.9x
Enterprise Value 524B 454B 429B 389B 729B 50,240B 735B 5,119B 1,973B 25,486B 1,969B 1,925B 81,026B EV / Sales 2026 *
7.76x
EV / Sales 2027 * 7.02x
Free-Float
95.71%
Yield 2026 *
2.62%
Yield 2027 * 2.75%
1 day-0.17%
1 week+4.67%
Current month+1.56%
1 month+4.03%
3 months+17.52%
6 months+17.59%
Current year+13.97%
1 week 246.77
Extreme 246.7701
264.65
1 month 246.77
Extreme 246.7701
266.96
Current year 190.75
Extreme 190.75
267.47
1 year 190.75
Extreme 190.75
267.47
3 years 135.85
Extreme 135.85
267.47
5 years 105.56
Extreme 105.56
267.47
10 years 55.06
Extreme 55.0623
267.47
Manager TitleAgeSince
Chief Executive Officer 55 2024-06-30
Director of Finance/CFO 59 2022-06-22
Chief Tech/Sci/R&D Officer - 2024-02-29
Director TitleAgeSince
Director/Board Member 65 2012-12-31
Director/Board Member 74 2012-12-31
Director/Board Member 69 2012-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/14/26 Exercice

Executive/Senior Manager

98,130 0.0056%
6/30/26 Free

Director

62 0.0000%
6/30/26 Free

Director

134 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.18%+4.67%+19.67%+71.19% 463B
+0.67%+1.74%+52.83%+98.63% 1,015B
-1.10%-2.27%+48.25%+62.90% 642B
-0.37%+2.71%+38.25%+37.75% 353B
-0.40%+1.29%+15.95%+22.74% 265B
-0.58%+1.48%+5.59%+10.16% 254B
-1.07%-4.31%+37.11%+44.30% 206B
-1.49%-5.57%-22.35%-58.63% 191B
-0.48%-1.34%+28.55%+91.19% 182B
-0.56%-1.24%+14.50%-19.45% 158B
Average -0.58%-3.28%+23.84%+36.08% 372.82B
Weighted average by Cap. -0.34%-2.22%+33.17%+55.44%

Financials

2026 *2027 *
Net sales 67.59B 58.57B 55.27B 50.14B 94.06B 6,478B 94.74B 660B 254B 3,286B 254B 248B 10,448B 73.49B 63.68B 60.09B 54.52B 102B 7,044B 103B 718B 277B 3,573B 276B 270B 11,360B
Net income 14.08B 12.2B 11.51B 10.44B 19.59B 1,349B 19.73B 137B 52.98B 685B 52.88B 51.71B 2,176B 19.09B 16.54B 15.61B 14.16B 26.56B 1,829B 26.75B 186B 71.83B 928B 71.69B 70.11B 2,950B
Net Debt 61.59B 53.37B 50.37B 45.69B 85.71B 5,903B 86.34B 602B 232B 2,995B 231B 226B 9,521B 53.09B 46B 43.41B 39.39B 73.88B 5,089B 74.42B 518B 200B 2,581B 199B 195B 8,207B
Logo AbbVie Inc.
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (76.2%), Germany (2.8%), Japan (2.1%), Canada (2%), China (1.6%), France (1.3%), the United Kingdom (1%), Spain (1%), Italy (0.9%), Brazil (0.8%), Australia (0.8%), and Other (9.5%).
Employees
57,000
Date Price Change Volume
26-09-15 $261.58 -0.07% 670,320
26-09-14 $261.77 +1.81% 4,512,420
26-09-11 $257.12 +0.83% 4,308,856
26-09-10 $255.00 +1.63% 4,397,653
26-09-09 $250.91 +0.86% 3,866,951
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
261.77USD
Average target price
278.61USD
Spread / Average Target
+6.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBV Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!